Lisanti Capital Growth LLC Sells 37,730 Shares of Xometry, Inc. $XMTR

Lisanti Capital Growth LLC trimmed its holdings in shares of Xometry, Inc. (NASDAQ:XMTRFree Report) by 31.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 82,455 shares of the company’s stock after selling 37,730 shares during the period. Lisanti Capital Growth LLC owned about 0.16% of Xometry worth $4,491,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also added to or reduced their stakes in the business. Sylebra Capital LLC lifted its position in shares of Xometry by 9.6% in the 2nd quarter. Sylebra Capital LLC now owns 2,062,157 shares of the company’s stock worth $69,680,000 after purchasing an additional 180,533 shares during the period. First Trust Advisors LP raised its stake in Xometry by 42.9% in the second quarter. First Trust Advisors LP now owns 1,279,005 shares of the company’s stock worth $43,218,000 after buying an additional 384,211 shares in the last quarter. Ameriprise Financial Inc. lifted its holdings in Xometry by 4.5% during the second quarter. Ameriprise Financial Inc. now owns 1,274,351 shares of the company’s stock worth $43,060,000 after buying an additional 54,996 shares during the period. Geode Capital Management LLC lifted its holdings in Xometry by 0.9% during the second quarter. Geode Capital Management LLC now owns 1,084,117 shares of the company’s stock worth $36,637,000 after buying an additional 9,360 shares during the period. Finally, New York State Common Retirement Fund boosted its position in Xometry by 1.0% during the 2nd quarter. New York State Common Retirement Fund now owns 951,142 shares of the company’s stock valued at $32,139,000 after acquiring an additional 9,054 shares in the last quarter. Hedge funds and other institutional investors own 97.31% of the company’s stock.

Xometry Trading Down 6.5%

Shares of Xometry stock opened at $57.13 on Friday. The firm has a market capitalization of $2.93 billion, a price-to-earnings ratio of -45.70 and a beta of 0.86. The company has a current ratio of 3.62, a quick ratio of 3.58 and a debt-to-equity ratio of 1.20. The firm’s 50 day simple moving average is $61.40 and its two-hundred day simple moving average is $53.06. Xometry, Inc. has a 12-month low of $18.59 and a 12-month high of $69.26.

Xometry (NASDAQ:XMTRGet Free Report) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.11 EPS for the quarter, meeting the consensus estimate of $0.11. Xometry had a negative net margin of 9.80% and a negative return on equity of 6.59%. The business had revenue of $180.72 million during the quarter, compared to analysts’ expectations of $168.25 million. During the same period in the previous year, the business posted $0.02 EPS. The business’s quarterly revenue was up 27.5% compared to the same quarter last year. Analysts predict that Xometry, Inc. will post -0.66 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. JPMorgan Chase & Co. boosted their price target on Xometry from $55.00 to $70.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Xometry in a report on Wednesday, January 21st. The Goldman Sachs Group raised their price target on shares of Xometry from $49.00 to $56.00 and gave the company a “neutral” rating in a report on Wednesday, November 5th. Citizens Jmp boosted their price objective on shares of Xometry from $65.00 to $75.00 and gave the stock a “market outperform” rating in a research note on Wednesday, November 5th. Finally, Cantor Fitzgerald increased their target price on shares of Xometry from $41.00 to $60.00 and gave the company a “neutral” rating in a research report on Wednesday, November 5th. Five research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $57.89.

Get Our Latest Stock Analysis on Xometry

Insider Activity

In other Xometry news, insider Subir Dutt sold 3,929 shares of the business’s stock in a transaction that occurred on Monday, January 5th. The stock was sold at an average price of $65.55, for a total transaction of $257,545.95. Following the completion of the sale, the insider directly owned 67,419 shares in the company, valued at approximately $4,419,315.45. The trade was a 5.51% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Sanjeev Singh Sahni sold 26,190 shares of the business’s stock in a transaction on Thursday, January 8th. The stock was sold at an average price of $65.47, for a total value of $1,714,659.30. Following the transaction, the president directly owned 63,130 shares in the company, valued at $4,133,121.10. This trade represents a 29.32% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 63,436 shares of company stock worth $4,165,072. Company insiders own 9.66% of the company’s stock.

Xometry Company Profile

(Free Report)

Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.

Read More

Want to see what other hedge funds are holding XMTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xometry, Inc. (NASDAQ:XMTRFree Report).

Institutional Ownership by Quarter for Xometry (NASDAQ:XMTR)

Receive News & Ratings for Xometry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xometry and related companies with MarketBeat.com's FREE daily email newsletter.